BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 15235604)

  • 1. Heterozygous TGFBR2 mutations in Marfan syndrome.
    Mizuguchi T; Collod-Beroud G; Akiyama T; Abifadel M; Harada N; Morisaki T; Allard D; Varret M; Claustres M; Morisaki H; Ihara M; Kinoshita A; Yoshiura K; Junien C; Kajii T; Jondeau G; Ohta T; Kishino T; Furukawa Y; Nakamura Y; Niikawa N; Boileau C; Matsumoto N
    Nat Genet; 2004 Aug; 36(8):855-60. PubMed ID: 15235604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome.
    Singh KK; Rommel K; Mishra A; Karck M; Haverich A; Schmidtke J; Arslan-Kirchner M
    Hum Mutat; 2006 Aug; 27(8):770-7. PubMed ID: 16799921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of TGFBR2 mutations in Marfan-syndrome-related disorders suggests a correlation between phenotypic severity and Smad signaling activity.
    Horbelt D; Guo G; Robinson PN; Knaus P
    J Cell Sci; 2010 Dec; 123(Pt 24):4340-50. PubMed ID: 21098638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 23 TGFBR2 and 6 TGFBR1 gene mutations and genotype-phenotype investigations in 457 patients with Marfan syndrome type I and II, Loeys-Dietz syndrome and related disorders.
    Stheneur C; Collod-Béroud G; Faivre L; Gouya L; Sultan G; Le Parc JM; Moura B; Attias D; Muti C; Sznajder M; Claustres M; Junien C; Baumann C; Cormier-Daire V; Rio M; Lyonnet S; Plauchu H; Lacombe D; Chevallier B; Jondeau G; Boileau C
    Hum Mutat; 2008 Nov; 29(11):E284-95. PubMed ID: 18781618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. May TGFBR1 act also as low penetrance allele in Marfan syndrome?
    Lucarini L; Evangelisti L; Attanasio M; Lapini I; Chiarini F; Porciani MC; Abbate R; Gensini G; Pepe G
    Int J Cardiol; 2009 Jan; 131(2):281-4. PubMed ID: 17936924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of Marfan syndrome.
    Boileau C; Jondeau G; Mizuguchi T; Matsumoto N
    Curr Opin Cardiol; 2005 May; 20(3):194-200. PubMed ID: 15861007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders.
    Mátyás G; Arnold E; Carrel T; Baumgartner D; Boileau C; Berger W; Steinmann B
    Hum Mutat; 2006 Aug; 27(8):760-9. PubMed ID: 16791849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two novel and one known mutation of the TGFBR2 gene in Marfan syndrome not associated with FBN1 gene defects.
    Disabella E; Grasso M; Marziliano N; Ansaldi S; Lucchelli C; Porcu E; Tagliani M; Pilotto A; Diegoli M; Lanzarini L; Malattia C; Pelliccia A; Ficcadenti A; Gabrielli O; Arbustini E
    Eur J Hum Genet; 2006 Jan; 14(1):34-8. PubMed ID: 16251899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new locus-specific database (LSDB) for mutations in the TGFBR2 gene: UMD-TGFBR2.
    Frederic MY; Hamroun D; Faivre L; Boileau C; Jondeau G; Claustres M; Béroud C; Collod-Béroud G
    Hum Mutat; 2008 Jan; 29(1):33-8. PubMed ID: 17935258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-phenotype analysis of F-helix mutations at the kinase domain of TGFBR2, including a type 2 Marfan syndrome familial study.
    Zhang L; Gao LG; Zhang M; Zhou XL
    Mol Vis; 2012; 18():55-63. PubMed ID: 22259224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel FBN1 and TGFBR2 mutations in 65 probands with Marfan syndrome or Marfan-like phenotypes.
    Chung BH; Lam ST; Tong TM; Li SY; Lun KS; Chan DH; Fok SF; Or JS; Smith DK; Yang W; Lau YL
    Am J Med Genet A; 2009 Jul; 149A(7):1452-9. PubMed ID: 19533785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marfan syndrome: from molecular pathogenesis to clinical treatment.
    Ramirez F; Dietz HC
    Curr Opin Genet Dev; 2007 Jun; 17(3):252-8. PubMed ID: 17467262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel microdeletion in the transforming growth factor beta type II receptor gene is associated with giant and large cell variants of nonsmall cell lung carcinoma.
    Wang JC; Su CC; Xu JB; Chen LZ; Hu XH; Wang GY; Bao Y; Huang Q; Fu SB; Li P; Lu CQ; Zhang RM; Luo ZW
    Genes Chromosomes Cancer; 2007 Feb; 46(2):192-201. PubMed ID: 17117417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the TGFBR2 gene in Chinese patients with Marfan-related syndrome.
    Chen J; Li B; Yang Y; Hu J; Zhao T; Gong Y; Tan Z
    Clin Invest Med; 2010 Feb; 33(1):E14-21. PubMed ID: 20144264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.
    Loeys BL; Chen J; Neptune ER; Judge DP; Podowski M; Holm T; Meyers J; Leitch CC; Katsanis N; Sharifi N; Xu FL; Myers LA; Spevak PJ; Cameron DE; De Backer J; Hellemans J; Chen Y; Davis EC; Webb CL; Kress W; Coucke P; Rifkin DB; De Paepe AM; Dietz HC
    Nat Genet; 2005 Mar; 37(3):275-81. PubMed ID: 15731757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis for diagnosis of Marfan syndrome and Marfan-associated disorders.
    Gao LG; Yao XP; Zhang L; Hui RT; Zhou XL
    Chin Med J (Engl); 2011 Mar; 124(6):930-4. PubMed ID: 21518605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shprintzen-Goldberg syndrome associated with a novel missense mutation in TGFBR2.
    van Steensel MA; van Geel M; Parren LJ; Schrander-Stumpel CT; Marcus-Soekarman D
    Exp Dermatol; 2008 Apr; 17(4):362-5. PubMed ID: 17979970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer.
    Biswas S; Chytil A; Washington K; Romero-Gallo J; Gorska AE; Wirth PS; Gautam S; Moses HL; Grady WM
    Cancer Res; 2004 Jul; 64(14):4687-92. PubMed ID: 15256431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells.
    Biswas S; Trobridge P; Romero-Gallo J; Billheimer D; Myeroff LL; Willson JK; Markowitz SD; Grady WM
    Genes Chromosomes Cancer; 2008 Feb; 47(2):95-106. PubMed ID: 17985359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.